Mild | Moderate | Severe | Total | Induction agent | |
Period | |||||
1 | 11% | 44% | 22% | 77% | (OKT3 or cyclophosphamide) |
2 | 17% | 43% | 34% | 94% | (mycophenolate mofetil) |
3 | 33% | 36% | 12% | 81% | (daclizumab) |
Mild | Moderate | Severe | Total | Induction agent | |
Period | |||||
1 | 11% | 44% | 22% | 77% | (OKT3 or cyclophosphamide) |
2 | 17% | 43% | 34% | 94% | (mycophenolate mofetil) |
3 | 33% | 36% | 12% | 81% | (daclizumab) |